Boesch M - Search Results

1

Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.

Boesch M, Horvath L, Baty F, Pircher A, Wolf D, Spahn S, Straussman R, Tilg H, Brutsche MH. Boesch M, et al. J Immunother Cancer. 2022 Nov;10(11):e005401. doi: 10.1136/jitc-2022-005401. J Immunother Cancer. 2022. PMID: 36343977 Free PMC article. Review.

2

Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.

Scheiblhofer S, Drothler S, Braun W, Braun R, Boesch M, Weiss R. Scheiblhofer S, et al. Among authors: boesch m. Vaccine. 2021 Jul 22;39(32):4399-4403. doi: 10.1016/j.vaccine.2021.06.068. Epub 2021 Jun 26. Vaccine. 2021. PMID: 34226102 Free PMC article.

3

DyeCycle Violet used for side population detection is a substrate of P-glycoprotein.

Boesch M, Reimer D, Rumpold H, Zeimet AG, Sopper S, Wolf D. Boesch M, et al. Cytometry A. 2012 Jun;81(6):517-22. doi: 10.1002/cyto.a.22038. Epub 2012 Mar 7. Cytometry A. 2012. PMID: 22407964 Free article.

4

The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics.

Boesch M, Zeimet AG, Reimer D, Schmidt S, Gastl G, Parson W, Spoeck F, Hatina J, Wolf D, Sopper S. Boesch M, et al. Oncotarget. 2014 Aug 30;5(16):7027-39. doi: 10.18632/oncotarget.2053. Oncotarget. 2014. PMID: 25216521 Free PMC article.

5

Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.

Boesch M, Zeimet AG, Rumpold H, Gastl G, Sopper S, Wolf D. Boesch M, et al. Stem Cells Transl Med. 2015 Sep;4(9):1028-32. doi: 10.5966/sctm.2015-0054. Epub 2015 Jul 1. Stem Cells Transl Med. 2015. PMID: 26136502 Free PMC article.

6

Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype.

Boesch M, Wolf D, Sopper S. Boesch M, et al. Stem Cells Int. 2016;2016:1652389. doi: 10.1155/2016/1652389. Epub 2015 Dec 20. Stem Cells Int. 2016. PMID: 26798352 Free PMC article.

7

High prevalence of side population in human cancer cell lines.

Boesch M, Zeimet AG, Fiegl H, Wolf B, Huber J, Klocker H, Gastl G, Sopper S, Wolf D. Boesch M, et al. Oncoscience. 2016 Apr 10;3(3-4):85-87. doi: 10.18632/oncoscience.300. eCollection 2016. Oncoscience. 2016. PMID: 27226981 Free PMC article.

8

Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions.

Boesch M, Sopper S, Wolf D. Boesch M, et al. Oncologist. 2016 Nov;21(11):1291-1293. doi: 10.1634/theoncologist.2016-0159. Epub 2016 Aug 2. Oncologist. 2016. PMID: 27486200 Free PMC article.

9

Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.

Boesch M, Sopper S, Zeimet AG, Reimer D, Gastl G, Ludewig B, Wolf D. Boesch M, et al. Biochim Biophys Acta. 2016 Dec;1866(2):276-289. doi: 10.1016/j.bbcan.2016.10.003. Epub 2016 Oct 15. Biochim Biophys Acta. 2016. PMID: 27751894 Free PMC article. Review.

10

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples.

Boesch M, Hoflehner E, Wolf D, Gastl G, Sopper S. Boesch M, et al. J Vis Exp. 2017 May 10;(123):55634. doi: 10.3791/55634. J Vis Exp. 2017. PMID: 28518118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters